Q2 LONG ANSWER 10M ★ High-yield

Describe the dose-response relationship. Explain potency, efficacy, agonists, antagonists and the therapeutic index.

Pharmacology · 2nd Professional — Para-Clinical

Types of Dose–response Relationship

Type	Measures	Curve	Use
Graded (quantitative)	The magnitude of response in one individual or tissue, increasing continuously with dose	Hyperbolic on a linear scale; sigmoid (S-shaped) on a semilogarithmic plot	Defines potency and efficacy
Quantal (all-or-none)	The proportion of a population showing a defined response at each dose	Cumulative frequency curve, also sigmoid	Defines ED50, TD50, LD50 and the therapeutic index

The semilogarithmic plot is used because it straightens the middle of the curve, allowing a wide range of doses on one graph and easy comparison of drugs
ED50 — the dose producing the specified effect in 50% of the population (quantal), or 50% of the maximal response (graded)

Potency and Efficacy

Feature	Potency	Efficacy (maximal efficacy)
Definition	The amount of drug needed to produce a given effect	The maximum response the drug can produce, however large the dose
Reflects	Affinity for the receptor	Intrinsic activity
Shown on the curve by	Position on the horizontal (dose) axis — a curve to the left is more potent	Height of the plateau (Emax)
Measured by	ED50	Emax
Clinical importance	Determines only the dose size — of little clinical consequence	The deciding factor in choosing a drug
Example	Frusemide is less potent than bumetanide (mg against microgram doses) but equally efficacious	Frusemide is more efficacious than a thiazide — it can produce a much greater diuresis, which is why it works in renal failure and a thiazide does not

CLINICAL PEARL

Efficacy matters clinically; potency almost never does. A more potent drug simply means a smaller tablet. What decides treatment is whether the drug can produce the effect you need at all — and no dose of a thiazide will match frusemide in severe cardiac failure. Advertising that emphasises milligram potency is therefore usually meaningless.

Agonists and Antagonists on the Curve

Class	Affinity	Intrinsic activity	Effect
Full agonist	Yes	1	Produces the maximal response
Partial agonist	Yes	Between 0 and 1	Submaximal response even at full occupancy; acts as an antagonist in the presence of a full agonist
Antagonist	Yes	0	No effect alone; blocks the agonist
Inverse agonist	Yes	−1	Produces the opposite effect by stabilising the inactive receptor state

Competitive and non-competitive antagonism

Feature	Competitive (reversible)	Non-competitive (irreversible)
Binding site	The same site as the agonist	A different (allosteric) site, or irreversible binding to the same site
Effect on the curve	Shifts it to the right, parallel	Flattens it — the maximum is reduced
Emax	Unchanged — can be restored by more agonist	Reduced — cannot be overcome
Surmountable	Yes	NO
Examples	Atropine against acetylcholine; naloxone against morphine; propranolol against adrenaline	Phenoxybenzamine against noradrenaline; aspirin on cyclo-oxygenase; omeprazole on the proton pump

Therapeutic Index and Drug Safety

The therapeutic index (TI) is the ratio of the dose producing toxicity to the dose producing the desired effect: TI = TD50 ÷ ED50 (or LD50/ED50 in animal studies).

A high therapeutic index means a safe drug — penicillin has a very high index; a low index means a dangerous one
Narrow therapeutic index drugs — digoxin, phenytoin, lithium, theophylline, warfarin, aminoglycosides, cytotoxics, insulin; these require therapeutic drug monitoring
The certain safety factor = TD1/ED99, and is a more stringent measure, because the therapeutic index compares two midpoints and ignores the spread of the curves — two drugs with the same index may differ greatly in how much their curves overlap

Other Concepts

Term	Meaning	Example
Therapeutic window	The range of plasma concentration between the minimum effective and the minimum toxic level	Digoxin 0.5–2.0 ng/mL
Ceiling effect	The point beyond which increasing the dose adds no further benefit but does add toxicity	Paracetamol and NSAIDs have an analgesic ceiling; opioids do not
Biphasic (hormetic) response	Opposite effects at low and high dose	Adrenaline: beta2 vasodilatation at low dose, alpha1 vasoconstriction at high dose
Threshold dose	The minimum dose producing any effect	—
Slope of the curve	A steep slope means a small dose change produces a large response change — less margin for error	Warfarin, insulin

Structure–activity Relationship and Drug Design

Structure–activity relationship (SAR) — small changes in chemical structure produce predictable changes in affinity, efficacy, selectivity and pharmacokinetics
Examples — adding a bulky substituent to the catecholamine nitrogen shifts activity from alpha to beta selectivity (adrenaline → isoprenaline); removing a hydroxyl group makes the molecule resistant to catechol-O-methyltransferase and orally active (salbutamol)
Isosteric substitution replaces an atom or group with one of similar size and electronic properties, retaining activity while altering metabolism
Enantiomers frequently differ — usually only one is active; S-warfarin is several times more potent than R-warfarin; the tragedy of thalidomide involved a racemic mixture whose enantiomers interconvert in the body
Rational drug design now begins from the three-dimensional structure of the target — as with the HIV protease inhibitors and the tyrosine kinase inhibitor imatinib

Applied Aspects

Choose a drug on efficacy and safety, not potency — the commonest error in interpreting drug promotion
Competitive antagonism can be overcome by raising the agonist dose, which is why very large doses of atropine are used in organophosphorus poisoning, and why naloxone must sometimes be repeated as it is shorter-acting than morphine
Irreversible antagonism requires new receptor synthesis to recover — aspirin’s effect on platelets lasts their whole 7 to 10 day lifespan because platelets have no nucleus
Monitor plasma levels for narrow-index drugs, and be alert to interactions, since a small change in concentration matters
The ceiling effect explains why opioids have no maximum analgesic dose, while paracetamol does — increasing paracetamol beyond the ceiling adds only hepatotoxicity
Individual variation means the population curve is only a guide; the dose must be titrated to the patient in front of you
A steep dose–response curve leaves little room for error — with warfarin and insulin a small dose change produces a large effect, which is why both are titrated against a measurement rather than given at a fixed dose
Combining drugs with different mechanisms allows a lower dose of each and so fewer dose-related effects — the rationale for combination antihypertensive and antitubercular therapy
The maximum tolerated dose is often below the maximally effective one, and it is toxicity rather than efficacy that sets the ceiling in practice — conspicuously so with cytotoxic drugs

All questions in General Pharmacology: Pharmacodynamics

Every Pharmacology chapter →